28 results
Thumbnail

D2.394 - Mycoplasma-Induced Drug Hypersensitivity: Rare Complication or Coincidence?

Thumbnail

D2.395 - Erdosteine-induced multifocal fied drug eruption: a case series of five patients

Thumbnail

D2.399 - Successful Deferasirox Desensitization in a Patient with Delayed-Type Hypersensitivity

Thumbnail

D2.402 - Latex Sensitization as a Risk Factor for Perioperative Hypersensitivity Reactions in Asthmatic Children

Thumbnail

D2.403 - When a Topical Drug Goes Systemic: A Case of Dual Hypersensitivity to Diltiazem

Thumbnail

D2.405 - UnDRESSing AGEP and Revealing Erythema Multiforme

Thumbnail

D2.406 - Severe DRESS in an oncohematological patient: diagnostic and therapeutic challenges

Thumbnail

D2.393 - Aspirin hypersensitivity and desensitization-Sense and sensibility

Thumbnail

D2.396 - Successful Desensitization in a Patient with a Delayed Type Hypersensitivity Reaction to Ethambutol

Thumbnail

D2.397 - Immediate and Delayed Hypersensitivity Reactions to Multiple Thyroid Hormone Preparations: A Challenging Case

Thumbnail

D2.398 - Ibuprofen Challenge or Desensitisation in Myo-Pericardial Disease: A Case Series

Thumbnail

D2.400 - Vitamin Hypersensitivity in the Era of Intravenous ‘Cocktails’: Diagnostic Pitfalls and Clinical Consequences

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project